Dr. Joseph L. Dellinger, MD

Dr. Dellinger practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Dellinger's NPI, 1740691377, was assigned on May 16, 2014. Dr. Dellinger graduated from Texas Tech University Health Sciences Center School of Medicine in 2013. Dr. Dellinger holds California license A136886.

Dr. Dellinger's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Dellinger's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. Dellinger is also affiliated with Huntington Hospital. The medical group on file is Optum - Downtown Los Angeles. Dmand AI also links Dr. Dellinger to 2 more medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dellinger practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Dellinger's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Dellinger is board certified in internal medicine by the American Board of Internal Medicine. Dr. Dellinger is licensed in California.

Dmand AI lists acute kidney failure, acute sinusitis, chronic diabetes, chronic hypertension, chronic kidney disease, circulation problems, congestive heart failure and contact dermatitis among the conditions Dr. Dellinger treats.

CMS data shows 692 Medicare services from Dr. Dellinger across 8 procedure codes in 2024, for 185 Medicare patients. Medicare paid $51,173 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Dellinger in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dellinger's median patient age at 67, with 51% women.

In 2024, Dr. Dellinger wrote 27 Medicare Part D claims. 85% of them were for generic drugs. They cover 4 drugs, with $333 in total drug cost. In 2017, CMS named 132 claims across 8 drugs.

Dr. Dellinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dellinger as offering telehealth.

Dmand AI links Dr. Dellinger to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Dermatitis, Atopic, Skin Diseases, Eczematous and Non-alcoholic Fatty Liver Disease. Open Payments lists research payments to Dr. Dellinger that name 3 trials.

CMS Open Payments shows 95 general payments to Dr. Dellinger from 12 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $55,651. It also lists 5 research payments totaling $5,326 from 2022 to 2024, naming 3 clinical trials.

Dr. Dellinger graduated from Texas Tech University Health Sciences Center School of Medicine in 2013.

Dr. Dellinger is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.